HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Keun Seok Lee Selected Research
Keun Seok Lee Research Topics
Disease
115
Breast Neoplasms (Breast Cancer)
05/2024 - 09/2005
57
Neoplasms (Cancer)
10/2023 - 08/2005
15
Neoplasm Metastasis (Metastasis)
04/2021 - 05/2009
11
Neutropenia
01/2024 - 07/2017
9
Disease Progression
04/2023 - 03/2008
8
Triple Negative Breast Neoplasms
05/2024 - 10/2016
7
Fatigue
02/2024 - 07/2007
6
Pathologic Complete Response
04/2023 - 02/2010
4
Anemia
01/2024 - 07/2017
3
Stomach Neoplasms (Stomach Cancer)
10/2023 - 02/2009
3
Exanthema (Rash)
07/2021 - 11/2017
3
Stomatitis
07/2021 - 11/2017
2
Hyperglycemia
07/2021 - 01/2021
2
Colorectal Neoplasms (Colorectal Cancer)
04/2021 - 06/2009
2
Body Weight (Weight, Body)
07/2020 - 01/2020
2
Cardiotoxicity
07/2020 - 07/2020
2
Febrile Neutropenia
01/2020 - 01/2016
2
Phyllodes Tumor (Cystosarcoma Phylloides)
07/2017 - 08/2009
2
Breast Cancer Lymphedema
07/2015 - 11/2014
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2006 - 06/2003
1
Chronic Disease (Chronic Diseases)
02/2024
1
Thrombocytopenia (Thrombopenia)
01/2024
1
Alopecia (Baldness)
12/2023
1
Nausea
12/2023
1
Vomiting
12/2023
Drug/Important Bio-Agent (IBA)
30
Hormones (Hormone)
IBA
10/2023 - 05/2009
17
Paclitaxel (Taxol)
FDA Link
Generic
01/2022 - 06/2003
14
Anthracyclines
IBA
11/2023 - 06/2008
14
human ERBB2 protein
IBA
04/2023 - 01/2011
13
Trastuzumab (Herceptin)
FDA Link
10/2022 - 01/2008
12
taxane
IBA
04/2023 - 05/2009
12
Gemcitabine
FDA Link
11/2019 - 10/2006
9
ErbB Receptors (EGF Receptor)
IBA
02/2024 - 06/2009
8
Estrogen Receptors
IBA
09/2023 - 03/2008
8
Everolimus
FDA Link
07/2021 - 11/2017
7
Biomarkers (Surrogate Marker)
IBA
05/2024 - 02/2006
7
Tamoxifen
FDA Link
Generic
04/2021 - 11/2010
6
Docetaxel (Taxotere)
FDA Link
07/2023 - 06/2008
6
Cyclophosphamide (Cytoxan)
FDA Link
Generic
07/2023 - 09/2005
6
Letrozole (Femara)
FDA Link
Generic
05/2021 - 06/2010
6
Capecitabine (Xeloda)
FDA Link
01/2019 - 06/2008
5
Doxorubicin (Adriamycin)
FDA Link
Generic
07/2020 - 06/2008
5
Lapatinib (GW572016)
FDA Link
12/2019 - 01/2011
5
Progesterone Receptors (Progesterone Receptor)
IBA
07/2018 - 04/2010
5
Cisplatin (Platino)
FDA Link
Generic
01/2018 - 06/2003
4
Alanine Transaminase (SGPT)
IBA
07/2021 - 01/2018
4
Irinotecan (Camptosar)
FDA Link
Generic
01/2019 - 06/2009
3
pembrolizumab
IBA
05/2024 - 01/2021
3
Vinorelbine (Navelbine)
FDA Link
Generic
11/2023 - 10/2010
3
Taxoids (Taxanes)
IBA
11/2023 - 12/2014
3
Phenobarbital (Luminal)
FDA Link
01/2023 - 12/2010
3
Biosimilar Pharmaceuticals
IBA
10/2022 - 01/2019
3
ribociclib
IBA
03/2022 - 01/2018
3
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 12/2010
3
exemestane (Aromasin)
FDA Link
07/2021 - 01/2012
3
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
07/2021 - 01/2018
3
Goserelin (Zoladex)
FDA Link
01/2021 - 06/2010
3
HM781-36B
IBA
12/2020 - 12/2018
3
Aromatase Inhibitors
IBA
11/2019 - 11/2011
3
Fulvestrant (Faslodex)
FDA Link
11/2019 - 01/2018
3
eribulin
FDA Link
11/2019 - 11/2017
3
Indicators and Reagents (Reagents)
IBA
01/2017 - 02/2006
2
B7-H1 Antigen
IBA
05/2024 - 02/2016
2
Enzymes
IBA
01/2024 - 11/2010
2
pegfilgrastim (Neulasta)
FDA Link
07/2023 - 01/2020
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
07/2023 - 09/2005
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
04/2023 - 06/2009
2
Androgen Receptors (Androgen Receptor)
IBA
04/2023 - 01/2019
2
trastuzumab deruxtecan
IBA
01/2022 - 01/2020
2
Circulating Tumor DNA
IBA
01/2022 - 01/2021
2
PF-05280014
IBA
01/2022 - 01/2019
2
pertuzumab
IBA
01/2022 - 12/2018
2
Cell-Free Nucleic Acids
IBA
10/2021 - 01/2018
2
Leuprolide (Lupron)
FDA Link
Generic
05/2021 - 01/2021
2
NVP-BKM120
IBA
01/2021 - 01/2018
2
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
01/2021 - 10/2018
2
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2019
2
Messenger RNA (mRNA)
IBA
12/2020 - 11/2010
2
Ado-Trastuzumab Emtansine
IBA
01/2020 - 12/2018
2
Radioisotopes (Radionuclides)
IBA
08/2019 - 04/2014
2
Indocyanine Green (Cardio-Green)
FDA Link
Generic
08/2019 - 04/2014
2
Epidermal Growth Factor (EGF)
IBA
01/2019 - 01/2016
2
Micelles
IBA
07/2017 - 03/2008
2
genexol-PM
IBA
07/2017 - 03/2008
2
Cytochrome P-450 CYP2D6 (CYP2D6)
IBA
01/2012 - 11/2010
2
Cetuximab (Erbitux)
FDA Link
11/2011 - 06/2009
2
Paraffin
IBA
12/2010 - 08/2010
2
Diphosphonates (Bisphosphonates)
IBA
06/2010 - 05/2009
1
olaparib
IBA
02/2024
Therapy/Procedure
38
Drug Therapy (Chemotherapy)
05/2024 - 12/2002
32
Therapeutics
02/2024 - 02/2006
15
Neoadjuvant Therapy
05/2024 - 01/2010
11
Radiotherapy
02/2024 - 12/2011
9
Segmental Mastectomy (Lumpectomy)
10/2017 - 12/2011
7
Adjuvant Chemotherapy
02/2024 - 09/2005
5
Combination Drug Therapy (Combination Chemotherapy)
11/2017 - 12/2002
4
Aftercare (After-Treatment)
01/2018 - 12/2014
2
Maintenance Chemotherapy
07/2015 - 05/2013
2
Terminal Care (Care, Terminal)
01/2013 - 08/2005
2
Mastectomy (Mammectomy)
12/2011 - 12/2011